• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.哈格曼因子(因子 XII)及哈格曼因子片段对纤溶酶原的激活作用。
J Clin Invest. 1978 Jul;62(1):54-60. doi: 10.1172/JCI109113.
2
Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.接触激活的纤维蛋白溶解:表面浓度和高分子量激肽原的作用
J Lab Clin Med. 1980 Aug;96(2):222-31.
3
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.C1抑制物对凝血因子片段激活凝血、纤维蛋白溶解和激肽生成的抑制作用。
J Clin Invest. 1973 Jun;52(6):1402-9. doi: 10.1172/JCI107313.
4
Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.血小板第4因子对哈格曼因子(因子Ⅻ)激活的抑制作用。
J Lab Clin Med. 1988 Sep;112(3):394-400.
5
Plasma inhibitors of the Hageman factor dependent pathways.接触因子依赖性途径的血浆抑制剂。
Semin Thromb Hemost. 1976 Jul;3(1):32-51.
6
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.高岭土和氯仿激活纤溶酶原的复杂机制研究:哈格曼因子及其他辅助因子的作用
J Clin Invest. 1969 Oct;48(10):1786-801. doi: 10.1172/JCI106145.
7
Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.曼氏血吸虫提取物对激活凝血因子 XII(哈格曼因子)的抑制作用。
J Lab Clin Med. 1992 Nov;120(5):735-9.
8
The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.前激肽释放酶和高分子量激肽原在硫酸脑苷脂及其他试剂对哈格曼因子(因子XII)的接触激活中的作用。
J Lab Clin Med. 1983 Oct;102(4):487-99.
9
Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor).纤溶酶原激活抑制剂(PA抑制剂)对活化的Hageman因子(因子XIIa)的抑制作用。
Thromb Res. 1978 Jun;12(6):1015-23. doi: 10.1016/0049-3848(78)90057-9.
10
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.弗莱彻因子缺乏症。由于缺乏前激肽释放酶导致哈格曼因子激活速率降低,伴有凝血、纤维蛋白溶解、趋化活性和激肽生成异常。
J Clin Invest. 1974 Feb;53(2):622-33. doi: 10.1172/JCI107597.

引用本文的文献

1
The complex role of kininogens in hereditary angioedema.激肽原在遗传性血管性水肿中的复杂作用。
Front Allergy. 2022 Aug 3;3:952753. doi: 10.3389/falgy.2022.952753. eCollection 2022.
2
Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.新型冠状病毒病凝血障碍中的血栓调节蛋白炎症:诊断和治疗策略的三个观点。
Front Immunol. 2021 Jun 11;12:649122. doi: 10.3389/fimmu.2021.649122. eCollection 2021.
3
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.血液凝固与 I 型和 II 型遗传性血管性水肿的发病机制。
Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6.
4
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.应用纤溶酶生成试验来确定氨甲环酸对剖宫产女性的药效学作用。
J Thromb Haemost. 2021 Jan;19(1):221-232. doi: 10.1111/jth.15114. Epub 2020 Dec 26.
5
Factor XII - What's important but not commonly thought about.凝血因子 XII——重要但常被忽视的因素。
Res Pract Thromb Haemost. 2019 Jun 19;3(4):599-606. doi: 10.1002/rth2.12235. eCollection 2019 Oct.
6
Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.多聚磷酸盐与血小板结合的纤维蛋白上的凝血因子XII共定位,并增强其纤溶酶原激活物活性。
Blood. 2016 Dec 15;128(24):2834-2845. doi: 10.1182/blood-2015-10-673285. Epub 2016 Sep 30.
7
Bradykinin: Inflammatory Product of the Coagulation System.缓激肽:凝血系统的炎症产物。
Clin Rev Allergy Immunol. 2016 Oct;51(2):152-61. doi: 10.1007/s12016-016-8540-0.
8
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.C1 酯酶抑制剂可减轻下肢缺血/再灌注损伤及相关肺损伤。
PLoS One. 2013 Aug 26;8(8):e72059. doi: 10.1371/journal.pone.0072059. eCollection 2013.
9
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.细菌纤溶酶原受体利用宿主纤溶酶原系统进行有效的侵袭和传播。
J Biomed Biotechnol. 2012;2012:482096. doi: 10.1155/2012/482096. Epub 2012 Oct 14.
10
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.C1抑制剂替代疗法用于脓毒性休克和高剂量白细胞介素-2诱导的血管渗漏综合征。
Intensive Care Med. 1993;19 Suppl 1:S19-28. doi: 10.1007/BF01738946.

本文引用的文献

1
Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).菲茨杰拉德特质:凝血、纤维蛋白溶解、激肽生成的表面介导反应以及稀释血浆增强血管通透性(PF/Dil)的 hitherto 尚未被识别的因子、菲茨杰拉德因子的缺乏。
J Clin Invest. 1975 May;55(5):1082-9. doi: 10.1172/JCI108009.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
[Role of the contact factor (Hageman factor) in fibrinolysis].[接触因子(哈格曼因子)在纤维蛋白溶解中的作用]
Thromb Diath Haemorrh. 1959 Sep 1;3:593-603.
4
PURIFICATION OF ACTIVATED BOVINE HAGEMAN FACTOR.活化牛哈格曼因子的纯化
Thromb Diath Haemorrh. 1963 Jul 31;35:546-56.
5
The purification of activated Hageman factor (activated factor XII).活化的哈格曼因子(活化的因子XII)的纯化。
Biochemistry. 1962 Nov;1:967-75. doi: 10.1021/bi00912a005.
6
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.弗莱彻因子缺乏症。由于缺乏前激肽释放酶导致哈格曼因子激活速率降低,伴有凝血、纤维蛋白溶解、趋化活性和激肽生成异常。
J Clin Invest. 1974 Feb;53(2):622-33. doi: 10.1172/JCI107597.
7
Plasminogen: purification from human plasma by affinity chromatography.纤溶酶原:通过亲和色谱法从人血浆中纯化。
Science. 1970 Dec 4;170(3962):1095-6. doi: 10.1126/science.170.3962.1095.
8
Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.人弗莱彻因子缺乏症血浆中凝血、纤维蛋白溶解和通透性增强系统的激活缺陷。
Circ Res. 1974 May;34(5):641-51. doi: 10.1161/01.res.34.5.641.
9
Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).活化的哈格曼因子(因子 XII)与血浆凝血活酶前体(因子 XI)之间反应产物的研究。
J Lab Clin Med. 1972 Nov;80(5):704-10.
10
Structural changes accompanying enzymatic activation of human Hageman factor.伴随人哈格曼因子酶促激活的结构变化
J Clin Invest. 1974 Sep;54(3):619-27. doi: 10.1172/JCI107799.

哈格曼因子(因子 XII)及哈格曼因子片段对纤溶酶原的激活作用。

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.

作者信息

Goldsmith G H, Saito H, Ratnoff O S

出版信息

J Clin Invest. 1978 Jul;62(1):54-60. doi: 10.1172/JCI109113.

DOI:10.1172/JCI109113
PMID:659637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC371736/
Abstract

Activation of plasminogen through surface-mediated reactions is well recognized. In the presence of kaolin, purified Hageman factor (Factor XII) changed plasminogen to plasmin, as assayed upon a synthetic amide substrate and by fibrinolysis. Kinetic studies suggested an enzymatic action of Hageman factor upon its substrate, plasminogen. Hageman factor fragments, at a protein concentration equivalent to whole Hageman factor, activated plasminogen to a lesser extent. These protein preparations were not contaminated with other agents implicated in surface-mediated fibrinolysis. Diisopropyl fluorophosphate treatment of plasminogen did not inhibit its activation by Hageman factor. These studies indicate that Hageman factor has a hitherto unsuspected function, the direct activation of plasminogen.

摘要

通过表面介导反应激活纤溶酶原已得到充分认识。在高岭土存在的情况下,经合成酰胺底物检测及纤维蛋白溶解检测,纯化的哈格曼因子(因子 XII)可将纤溶酶原转变为纤溶酶。动力学研究表明哈格曼因子对其底物纤溶酶原具有酶促作用。哈格曼因子片段在与完整哈格曼因子相当的蛋白质浓度下,对纤溶酶原的激活程度较小。这些蛋白质制剂未被其他与表面介导纤维蛋白溶解有关的因子污染。用二异丙基氟磷酸处理纤溶酶原并不抑制其被哈格曼因子激活。这些研究表明,哈格曼因子具有一种迄今未被怀疑的功能,即直接激活纤溶酶原。